diagnosed

Documents about diagnosed

• Pembrolizumab for Newly Diagnosed Glioblastoma#249600ClinicalTrials.gov
• SurVaxM Plus Adjuvant Temozolomide for Newly Diagnosed Glioblastoma (SURVIVE)#893050ClinicalTrials.gov
• Low Dose Teclistamab in Newly Diagnosed Multiple Myeloma Patients#862085ClinicalTrials.gov
• RN1201 Injection in Newly Diagnosed High-Risk Cytogenetic Multiple Myeloma#903447ClinicalTrials.gov
• Antisense102: Pilot Immunotherapy for Newly Diagnosed Malignant Glioma#870711ClinicalTrials.gov
• AraC for Newly Diagnosed Adult Langerhans Cell Histiocytosis#828335ClinicalTrials.gov
• Zanubrutinib Plus BR in Newly Diagnosed Symptomatic WM#909133ClinicalTrials.gov
• Phase II Study of Decitabine and Cytarabine for Older Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)#895520ClinicalTrials.gov
• Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma#454037ClinicalTrials.gov
• Iberdomide (Cc220) Maintenance After Asct in Newly Diagnosed MM Patients#870573ClinicalTrials.gov
• Temozolomide in Patients With Newly Diagnosed Anaplastic Oligodendroglioma and Mixed Oligoastrocytoma#829948ClinicalTrials.gov
• A Clinical Study of Hanlikang and BTK Inhibitors in the Treatment of Newly Diagnosed Mantle Cell Lymphoma#897452ClinicalTrials.gov
• Physical Activity Intervention for Individuals Newly Diagnosed With MS#899919ClinicalTrials.gov
• ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma#979038ClinicalTrials.gov
• Anxiety and depression in newly diagnosed epilepsy: A Matter of psychological history?#301035HAL (France)
• A Prospective, Multicentre European Registry for Newly Diagnosed Patients With Myelodysplastic Syndromes#829550ClinicalTrials.gov
• Study of SA+X in the Treatment of Newly Diagnosed AML#850322ClinicalTrials.gov
• Bortezomib, Lenalidomide and Dexamethasone Combination Therapy in Patients With Newly Diagnosed Multiple Myeloma#875214ClinicalTrials.gov
• Liquid Biopsy Based NGS in Newly Diagnosed NSCLC#226272ClinicalTrials.gov
• VRD as Induction Followed by VR Maintenance in Patients With Newly Diagnosed High Risk Multiple Myeloma#873091ClinicalTrials.gov
• Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML#873194ClinicalTrials.gov
• Navigated Early Survivorship Transition in Patients With Newly Diagnosed Cancer and Their Caregivers#992665ClinicalTrials.gov
• Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients#143749ClinicalTrials.gov
• Clinical Trial to Assess the Efficacy and Safety of 'Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea#845834ClinicalTrials.gov
• A Phase 1b/2 Study of PLX3397 + Radiation Therapy + Temozolomide in Patients With Newly Diagnosed Glioblastoma#854870ClinicalTrials.gov
• VA vs DA for Newly Diagnosed Hig-risk AML#881664ClinicalTrials.gov
• Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide#908868ClinicalTrials.gov
• LINC00511/miR-185-3p Axis and miR-301a-3p Markers for Breast Cancer Diagnosis#814026ClinicalTrials.gov
• MA+AZA Regimen for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML)#841952ClinicalTrials.gov
• Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML#850085ClinicalTrials.gov
• Levetiracetam Versus Standard Antiepileptic Drugs (Carbamazepine and Valproate) Used as Monotherapy in Patients With Newly Diagnosed Epilepsy#900083ClinicalTrials.gov
• Study to Evaluate Ibudilast and TMZ Combo Treatment in Newly Diagnosed and Recurrent Glioblastoma#829217ClinicalTrials.gov
• Study of the Poly (ADP-ribose) Polymerase-1 (PARP-1) Inhibitor BSI-201 in Patients With Newly Diagnosed Malignant Glioma#1010898ClinicalTrials.gov
• Cilengitide, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma and Methylated Gene Promoter Status#967582ClinicalTrials.gov
• Sperm Banking Among Adolescents Newly Diagnosed With Cancer: Development of a Profiling and Referral Tool#845317ClinicalTrials.gov
• A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma#868844ClinicalTrials.gov
• A Trauma-Informed Intervention for the Newly HIV-Diagnosed#966368ClinicalTrials.gov
• Venetoclax and Azacitidine Combined With Chidamide (VAC) for the Treatment of Newly Diagnosed Acute Monocytic Leukemia#841390ClinicalTrials.gov
• GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma Patients#18582ClinicalTrials.gov
• Coarctation of the aorta diagnosed in adulthood#416117PubMed Central
• A Prospective Cohort Study for Establishing Clinical Excellence in Patients With Newly Diagnosed Type 1 and Type 2 Diabetes and Prediabetes#852242ClinicalTrials.gov
• Effect of Radiation Therapy Plus Temozolomide Combined With Cilengitide or Cetuximab on the 1-year Overall Survival of Patients With Newly Diagnosed MGMT-promoter Unmethylated Glioblastoma#915244ClinicalTrials.gov
• 6 Months Adjuvant Temozolomide (TMZ) vs No Adjuvant TMZ in Newly Diagnosed MGMT Methylated Glioblastoma (GBM)#872343ClinicalTrials.gov
• Phase I EGFR BATs in Newly Diagnosed Glioblastoma#18617ClinicalTrials.gov
• Prediabetes and Newly Diagnosed Diabetes in Chronic Heart Failure#353430ClinicalTrials.gov
• Conditioning SCID Infants Diagnosed Early#394609ClinicalTrials.gov
• Vortioxetine for Newly Diagnosed Glioblastoma#875762ClinicalTrials.gov
• A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Newly Diagnosed Glioblastoma#829317ClinicalTrials.gov
• Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia#885106ClinicalTrials.gov
• A Phase 2 Study of Bcl-2 Inhibitor Combined With Azacitidine for Newly Diagnosed Mixed Phenotype Acute Leukemia#902397ClinicalTrials.gov